ChiCTR2500104968 版本V1.0 版本创建时间2025/06/26 09:35:47 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500104968 

最近更新日期:

Date of Last Refreshed on:

2025-06-26 09:35:30 

注册时间:

Date of Registration:

2025-06-26 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

结直肠癌术后患者久坐行为影响因素剖面分析——混合性研究

Public title:

Profile analysis of influencing factors on sedentary behavior of postoperative colorectal cancer patients——Mixed-methods research

注册题目简写:

English Acronym:

研究课题的正式科学名称:

结直肠癌术后患者久坐行为剖面分析及影响因素研究--混合性研究

Scientific title:

Profile analysis of influencing factors on sedentary behavior of postoperative colorectal cancer patients——Mixed-methods research

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

余美红 

研究负责人:

余美红 

Applicant:

Yu Meihong 

Study leader:

Yu Meihong 

申请注册联系人电话:

Applicant telephone:

+86 158 5919 1221

研究负责人电话:

Study leader's
telephone:

+86 158 5919 1221

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

361201253@qq.com

研究负责人电子邮件:

Study leader's E-mail:

361201253@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省福州市西二环北路156号

研究负责人通讯地址:

福建省福州市西二环北路156号

Applicant address:

156 West Second Ring North Road, Fuzhou City, Fujian Province

Study leader's address:

156 West Second Ring North Road, Fuzhou City, Fujian Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

联勤保障部队第九〇〇医院

Applicant's institution:

the 900th Hospital of the Joint Support Force

研究负责人所在单位:

联勤保障部队第九〇〇医院

Affiliation of the Leader:

the 900th Hospital of the Joint Support Force

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

伦审科第2025-005号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

联勤保障部队第九〇〇医院生物医学伦理委员会

Name of the ethic committee:

Biomedical Ethics Committee of the 900th Hospital of the Joint Support Force

伦理委员会批准日期:

Date of approved by ethic committee:

2025-04-21 00:00:00

伦理委员会联系人:

李云凤

Contact Name of the ethic committee:

Li Yunfeng

伦理委员会联系地址:

福州市西二环北路156号

Contact Address of the ethic committee:

156 West Second Ring North Road, Fuzhou City, Fujian Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 591 2285 9650

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

联勤保障部队第九〇〇医院

Primary sponsor:

the 900th Hospital of the Joint Support Force

研究实施负责(组长)单位地址:

福州市西二环北路156号

Primary sponsor's address:

156 West Second Ring North Road, Fuzhou City, Fujian Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建省

市(区县):

福州

Country:

China

Province:

Fujian Province

City:

Fuzhou

单位(医院):

联勤保障部队第九〇〇医院

具体地址:

福州市西二环北路156号

Institution
hospital:

the 900th Hospital of the Joint Support Force

Address:

156 West Second Ring North Road, Fuzhou City, Fujian Province

经费或物资来源:

Source(s) of funding:

none

研究疾病:

结直肠癌  

Target disease:

colorectal cancer

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

分析结直肠癌术后患者久坐行为潜在类别促进因素及阻碍因素,通过潜在剖面分析方法,探讨结直肠患者久坐行为潜在类别及其影响因素。  

Objectives of Study:

analyze the potential promotion and hindrance factors of sedentary behavior in patients with colorectal cancer after surgery, and to explore the potential categories and influencing factors of sedentary behavior in patients with colorectal cancer through latent profile analysis.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.经《2023 年版中国结直肠癌诊疗规范》确诊为结直肠癌者; 2.通过《Barthel 指数评定表》评分为 100 分,日常生活能力完全自理; 3.接受结直肠癌手术治疗出院后进行化疗患者; 4.签署知情同意书并参加本研究。

Inclusion criteria

1. Those diagnosed with colorectal cancer by the "2023 Edition of China's Colorectal Cancer Diagnosis and Treatment Guidelines"; 2. Those who passed the "Barthel Index Rating Scale" score of 100 points and were completely self-sufficient in daily living; 3. Patients who received colorectal cancer surgery and were discharged from the hospital after chemotherapy; 4. Sign the informed consent form and participate in this study.

排除标准:

1.有精神疾病或认知障碍者; 2.不能语言沟通者; 3.永久性造口患者; 4.有严重心血管疾病和肢体活动障碍患者。

Exclusion criteria:

1. Persons with mental illness or cognitive impairment; 2. Those who cannot communicate with language; 3. Patients with permanent stoma; 4. Patients with severe cardiovascular disease and physical mobility disorders.

研究实施时间:

Study execute time:

From 2025-01-01 00:00:00 To 2026-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-07-01 00:00:00 To 2025-12-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

375

Group:

Trial group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建省 

市(区县):

福州市 

Country:

China

Province:

Fujian Province

City:

Fuzhou

单位(医院):

联勤保障部队第九〇〇医院 

单位级别:

三甲 

Institution
hospital:

the 900th Hospital of the Joint Support Force

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

一般情况调查问卷

指标类型:

次要指标

Outcome:

General survey questionnaire

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

国际体力活动问卷

指标类型:

主要指标

Outcome:

International Physical Activity Questionnaire,IPAQ

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

久坐行为日记

指标类型:

主要指标

Outcome:

Sedentary Behavior Diary

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

医院焦虑抑郁情绪量表

指标类型:

次要指标

Outcome:

Hospital Anxiety and depression scale,HADS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

none

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究结束后以文章的方式共享。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

questionnaire

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1、病例记录表; 2、电子病例管理系统。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1.Case record form 2.Electronics Medical Records Management System(EMRS)

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-06-26 09:35:30